Daily Stock List
OxySure Systems, Inc. (OXYS)
PennyStocks24, RedChip, TaglichBrothers, TopPennyStockMovers, BUYINS.NET, SECFilings.com News, and Vantage Wire reported on OxySure Systems, Inc. (OXYS), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
OxySure Systems, Inc. is a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology. A medical technology company, OxySure Systems focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. It pioneered a safe and easy-to-use solution to produce medically pure (USP) oxygen from inert powders. OxySure Systems is based in Frisco, Texas. The Company lists on the OTC Markets’ OTCQB.
OxySure Systems owns numerous issued patents and patents pending on the above-mentioned technology. This technology makes the provision of emergency oxygen safer, more accessible, as well as easier to use than traditional oxygen provision systems. The Company’s products improve access to emergency oxygen that affects the survival, recovery, and safety of individuals in many areas of need.
The proprietary process and methodology is for the emergency/short duration oxygen supply marketplace. With this technology, oxygen is generated on demand and there is no storage of oxygen. In addition, there are no compressed tanks, dials, valves, or regulatory maintenance. Furthermore, there is no hydrostatic testing, no batteries, no required training, and none of the hazards associated with traditional oxygen provision systems.
The Company’s launch product using this technology is the OxySure Model 615. This is a portable emergency oxygen device for lay person use. Model 615 bridges the gap between the beginning of a medical emergency and the time first responders arrive on the scene.
In early December, OxySure Systems announced that the Company signed an exclusive distribution agreement with HTM Medico Pte Ltd in Singapore. The agreement appoints HTM Medico as OxySure Systems’ exclusive distributor in Singapore. The agreement requires an annual minimum purchase commitment of 1,250 units of Model 615, valuing the contract at $1.3 million in the first 5 years.
Last week, OxySure Systems announced that it signed an exclusive long-term agreement with two-time USA Olympian and Sydney Games' Team USA Flag Bearer Cliff Meidl who has been a spokesperson for construction, electrical and Call 811 safety.
Julian T. Ross, OxySure Systems’ Chief Executive Officer, said, "We are excited to welcome Cliff Meidl to our OxySure Team. As an Olympian and CPR recipient, his safety and health mission can continue to resonate with OxySure both in the U.S. and globally."
Today, OxySure Systems announced that its Spokesman Cliff Meidl will participate in the 2015 Rose Bowl Parade to take place on January 1, 2015.
OxySure Systems, Inc. (OXYS), closed Tuesday's trading session at $0.766, up 4.93%, on 111,521 volume with 55 trades. The average volume for the last 60 days is 79,691 and the stock's 52-week low/high is $0.4499/$1.40.
Mountain High Acquisitions Corp. (MYHI)
SmallCapVoice, Integrity Solution IR, Charms Investments LTD, FivedollarMovers.net, Wallstreet Profiler, and PennyDoctor reported earlier on Mountain High Acquisitions Corp. (MYHI), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
Mountain High Acquisitions Corp. is a strategic real estate holding company listed on the OTCQB. The Company’s primary emphasis is the acquisition and development of commercial properties to be leased and used by the marijuana industry. Its present portfolio includes three Colorado properties zoned for commercial marijuana cultivation: Isabelle, Madison, and Pueblo. Mountain High Acquisitions has its corporate headquarters in Denver, Colorado.
Mountain High’s focus is to serve the marijuana industry as a landlord providing value-added, state-of-the-art facilities and services. The Company, by way of its wholly-owned subsidiary, Canna-Life Corp., is the current holder of purchase options on the three above-mentioned real estate properties zoned by the State of Colorado and municipal authorities for the cultivation of marijuana. Mountain High Acquisitions does not, and will not grow, harvest, distribute, or sell cannabis or any substances that violate U.S. law or the Controlled Substances Act. It has no intention to do so in the future.
The Company’s tenants are licensed growers. The State of Colorado limits the number of commercial marijuana growers’ licenses. Therefore, the market of available tenants is tightly controlled and well understood. At present, Mountain High believes existing demand from the licensed growers with whom it is in contact is more than adequate to fill any vacancy on its properties.
Earlier this year, Mountain High Acquisitions announced that Canna-Life completed the definitive Master Property Purchase and Sale Agreement for the acquisition of three properties and improvements located in Lafayette, Boulder County, Colorado, referred to as the Isabelle Property; Avondale, Pueblo County, Colorado, referred to as the Pueblo Property; and Denver, Denver County, Colorado, referred to as the Madison St. Property.
Mountain High earlier announced that it signed a Letter-of-Intent (LOI) to acquire property and related structures in Pueblo, Colorado. The 2.38 acre parcel of industrial land has been zoned by the State of Colorado and municipal authorities for the cultivation of marijuana and preparation of marijuana related products.
In September 2014, Mountain High announced that it completed all pre-closing due diligence regarding its previously announced LOI to acquire the 2.38 acre property and related structures in Pueblo, Colorado, known as the Greenhorn Property. The property presently holds an approximately 2,800 sq. ft. industrial use structure. It includes full grow rights for municipal water and a zoning allowance to build the whole footprint of the property two stories high with no set back.
In October, Mountain High Acquisitions announced that it appointed Mr. Richard G. Stifel as its new Chief Financial Officer (CFO) and Director. Mr. Stifel has more than 30 years of finance, accounting, and operations experience in telecom, trucking, mining, distribution, consumer products, video production, manufacturing, and retail. He has more than 15 years' experience as a CFO.
Mountain High Acquisitions Corp. (MYHI), closed Tuesday's trading session at $0.075, even for the day, on 34,681 volume with 8 trades. The average volume for the last 60 days is 64,636 and the stock's 52-week low/high is $0.021/$15.00.
Sevion Therapeutics, Inc. (SVON)
Today we are reporting on Sevion Therapeutics, Inc. (SVON), here at the QualityStocks Daily Newsletter.
Headquartered in San Diego, California, Sevion Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and acquires next-generation biologics. It is building and developing a portfolio of innovative therapeutics, from internal discovery and acquisition, for the treatment of cancer and immunological diseases. OTC Bulletin Board listed, the Company previously went by the name Senesco Technologies, Inc. It changed its corporate name to Sevion Therapeutics, Inc. in October of this year.
Sevion’s product candidates come from numerous key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong antibody scaffolds, and Chimerasome nanocages. Sevion has taken advantage of these technologies to build a pipeline of innovative product candidates.
Its antibody pipeline is undergoing development from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, including multispanning membrane proteins and ion channels that play an important role in multiple diseases. In addition, Sevion developed the first protein nanocage system enabling delivery of nucleic acids and other payloads to target cells.
Earlier this month, Sevion Therapeutics announced the presentation of results from its Phase 1b/2a clinical trial of SNS01-T for the treatment of multiple myeloma and lymphoma. The results were presented in a poster session titled “Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III” at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition in San Francisco, California.
Mr. Ronald Martell, Chief Executive Officer of Sevion Therapeutics, said, “Modulation of Factor 5A has the potential to regulate programmed cell death and improve patient outcomes in B-cell Lymphoma and other cancers. While we assess a path forward for SNS01-T, we will continue to focus our resources on our novel antibody technologies.”
Yesterday, Sevion Therapeutics announced a collaboration agreement with CNA Development, LLC, an affiliate of Janssen Pharmaceuticals, Inc., to discover antibodies using Sevion’s spatially addressed library platform. The collaboration facilitated by the Johnson & Johnson Innovation center in California will include discovery of antibodies against multiple targets in a number of therapeutic areas.
Sevion Therapeutics and Janssen Pharmaceuticals will jointly conduct research on antibodies discovered by Sevion. Janssen will have an option to an exclusive license to develop, manufacture, and commercialize candidates resulting from the collaboration.
Sevion Therapeutics, Inc. (SVON), closed Tuesday's trading session at $1.04, down 6.31%, on 91,115 volume with 102 trades. The average volume for the last 60 days is 39,022 and the stock's 52-week low/high is $0.51/$6.35.
diaDexus, Inc. (DDXS)
Streetwise Reports, MomentumOTC, Pumps and Dumps, PennyStocks24, SecretStockPromo, StockOnion, PennyStockProphet, Buzz Stocks, Planet Penny Stocks, Penny Pick Finders, and TaglichBrothers reported on diaDexus, Inc. (DDXS), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
South San Francisco, California based diaDexus, Inc. is a commercial stage developer of proprietary cardiovascular diagnostic products. The Company develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. diaDexus is ISO 13485 certified. The Company also has heart failure biomarkers for future development. diaDexus lists on the OTC Markets’ OTCQB.
Its PLAC® Test ELISA Kit is the only blood test cleared by the U.S. Food and Drug Administration (FDA) to aid in predicting risk for coronary heart disease and ischemic stroke associated with atherosclerosis. Its PLAC® Test for Lp-PLA2 Activity, a CE-marked test, is an indicator of atherosclerotic cardiovascular disease. diaDexus manufactures the PLAC® Test for Lp-PLA2 Activity on-site.
The PLAC Test for Lp-PLA2 Activity is an enzyme assay for the quantitative determination of Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) activity in human plasma and serum. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) is a vascular-specific inflammatory marker, which is critical in the formation of rupture-prone plaque.
When elevated, this enzyme indicates arterial inflammation, which is associated with greater risk for cardiovascular disease. The PLAC® Test for Lp-PLA2 Activity is to be used in combination with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease in patients with no prior history of cardiovascular events.
diaDexus announced this past July that it received notice from the FDA that an administrative acceptance review was conducted on the traditional 510(k) submission of the PLAC Test for Lp-PLA2 Activity. It was found to contain all of the necessary information needed to proceed with the substantive review.
This month, diaDexus announced the appointment of Mr. Pat Arensdorf as General Manager and head of the heart failure business unit. Mr. Arensdorf has responsibility for the development and commercialization of the Company’s heart failure biomarkers. He has over 20 years of experience in the medical technology industry.
Furthermore, this month, diaDexus announced that it received 510(k) clearance from the FDA for its PLAC® Test for Lp-PLA2 Activity. This new test is an enzyme assay for the quantitative determination of Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) activity in human plasma and serum. An analysis based on REGARDS, a U.S.-based National Institutes of Health (NIH)-funded longitudinal study, using a cohort of around 4,500 individuals with no prior history of cardiovascular events, demonstrated that elevated Lp-PLA2 Activity levels are associated with a considerable increase for risk of coronary heart disease.
diaDexus, Inc. (DDXS), closed Tuesday's trading session at $0.414, up 27.38%, on 1,695,894 volume with 204 trades. The average volume for the last 60 days is 255,283 and the stock's 52-week low/high is $0.2813/$1.18.
Quantum Materials Corp. (QTMM)
PennyStocks Forever, The MicrocapNews, BUYINS.NET, AddictivePennyStocks, PricelessPenny, PennyStockRumors.net, Bullseyestox.com, and PennyStocks24 reported earlier on Quantum Materials Corp. (QTMM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Quantum Materials Corp. manufactures Tetrapod Quantum Dots for use in medical, display, solar energy and lighting applications via its patent-pending volume production process. Tetrapod Quantum Dot semiconductors permit a new level of engineered performance for consumer and industrial products. Quantum dots fall into the category of nanocrystals. This additionally includes quantum rods and nanowires. Quantum Materials is headquartered in San Marcos, Texas.
The Company has its its wholly-owned subsidiary, Solterra Renewable Technologies, Inc. Solterra focuses on manufacturing solar cells for retail electricity markets in North America, Europe, the Middle East, and Asia. Solterra Renewable Technologies develops sustainable solar technology through replacing silicon wafer-based solar cells with high-production, low-cost, efficient and flexible thin-film quantum dot solar cells. Solterra plans to market a thin-film photovoltaic cell incorporating the Company’s proprietary quantum dot semiconductors.
Regarding Quantum Dots, they measure near one billionth of an inch. They are a non-traditional type of semiconductor. They can be used as an enabling material across numerous industries. They have first-rate versatility and are flexible in form.
Solterra will employ Quantum Materials’ exclusive license from University of Arizona Regents for Dr. Ghassan Jabbour’s patented printing technology in the production of its solar cells. Solterra’s goal is to become the first solar cell manufacturer that can offer a solar electricity solution, which competes on a non-subsidized basis with the price of retail electricity in the aforementioned key markets.
Quantum Materials announced in June 2014 securing 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology. This was developed at the Institute for Critical Technology and Applied Science and the Design, Research, and Education for Additive Manufacturing Systems (DREAMS) Laboratory at Virginia Tech. The technology embeds quantum dots within objects being 3D printed to produce a unique, physically uncloneable signature known only to the object's manufacturer.
Recently, Quantum Materials announced that it signed an agreement with STAR Park, which will quadruple the Company’s Quantum Dot production space when the new state-of-the-art lab and offices are finished on or before June 2015. In addition, Quantum Materials is recruiting to double its scientific staff effective January 2015.
Quantum Materials Corp. (QTMM), closed Tuesday's trading session at $0.1488, down 8.35%, on 305,195 volume with 44 trades. The average volume for the last 60 days is 362,631 and the stock's 52-week low/high is $0.033/$0.45.
Relmada Therapeutics, Inc. (RLMD)
Wallstreetbuzz, Investopedia, Investors Alley, ProfitableTrading, and WallstreetsHotteststocks reported earlier on Relmada Therapeutics, Inc. (RLMD), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company whose shares trade on the OTCQB. The Company focuses on developing novel versions of proven drug products in conjunction with new chemical entities, which potentially address areas of high unmet medical need in the treatment of pain. Relmada Therapeutics has its headquarters in New York, New York.
The Company has a varied portfolio of four lead products at different stages of development. These products include LevoCap ER, d-Methadone, MepiGel, and BuTab ER. LevoCap ER is a proprietary once-a-day extended release dosage form of the opioid analgesic levorphanol. LevoCap ER is in an abuse deterrent drug delivery system. It is a new tamper-resistant, extended release form of levorphanol.
Relmada Therapeutics’ d-Methadone is the d optical isomer of racemic methadone and an antagonist at the N-methyl-D-aspartate (NMDA) receptor. Furthermore, its MepiGel is a proprietary topical dosage form of the local anesthetic mepivacaine for the treatment of painful peripheral neuropathies. BuTab ER is a proprietary once-a-day extended release dosage form of oral buprenorphine. It is undergoing development for the treatment of chronic moderate to moderately severe pain and opioid dependence.
Relmada Therapeutics has entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of LevoCap ER. Gavril Pasternak, MD, PhD, of MSKCC is the lead investigator for these studies.
In early December, Relmada Therapeutics announced that it received a No Objection Letter (NOL) from Health Canada to conduct the first pharmacokinetic and pharmacodynamic study with d-Methadone, the Company’s N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain, in Canada. Neuropathic pain is defined as a disorder of the sensorimotor system. It is clearly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation.
Yesterday, Relmada Therapeutics announced that the first cohort of subjects has been dosed in a pharmacokinetic and pharmacodynamic study with d-Methadone.
Dr. Sergio Traversa, Relmada Therapeutics’ CEO, stated, “We are pleased to announce that the first subjects have been dosed in a Phase I clinical trial evaluating the safety and tolerability of d-Methadone. The data generated will help guide our determination of the appropriate dose of this drug for the treatment of neuropathic pain conditions, which we believe is currently a large and unsatisfied market."
Relmada Therapeutics, Inc. (RLMD), closed Tuesday's trading session at $3.00, up 0.33%, on 113,519 volume with 226 trades. The average volume for the last 60 days is 5,158 and the stock's 52-week low/high is $1.50/$4.00.
Epoxy, Inc. (EPXY)
Today we are highlighting Epoxy, Inc. (EPXY), here at the QualityStocks Daily Newsletter.
Listed on the OTC Markets’ OTCQB, Epoxy, Inc. is the developer of the Epoxy app, which is an application or "app" for iPhone iOS and Android operating systems. Epoxy is an innovative smart phone application. The design of it is to conveniently connect business owners and consumers to ease marketing frustrations. The Company was previously known as Neohydro Technologies Corp. It changed its name to Epoxy, Inc. in August of this year. In essence, Epoxy is a fully integrated mobile application business. Epoxy has its corporate headquarters in Las Vegas, Nevada.
The Epoxy mobile app gives loyal customers the ease of keeping track of rewards and punch cards all in one place. This is while additionally giving opportunities to review and share businesses with friends. Sequentially, Epoxy provides businesses the ability to reward, share offers, as well as deliver information regarding special events with its customers, and offer card-less gift cards directly via smart phones.
This month, Epoxy announced the launch of the Company’s new website and sales video designed and produced by Wheat Creative. The new website including new branding has been handled directly by Wheat Creative to help Epoxy better identify to both its users and clients and assisting in the potential increase in sales. Moreover, Wheat Creative has also made a sales video to help better explain Epoxy to new and potential clients and app users. Furthermore, Epoxy also engaged Carter Terry and Company to assist with its capital and lending needs.
Wheat Creative is a fully integrated digital marketing firm with more than 20 years’ experience in hospitality, retail and food and beverage with award winning concepts and branding.
Mr. David Gasparine, Chief Executive Officer of Epoxy, said, "This is an exciting group to be involved with, for both our web based presence and our tactile marketing already in stores. We hope Wheat will also allow us to better identify with new users and clients in a modern, sophisticated way."
Epoxy, Inc. (EPXY), closed Tuesday's trading session at $0.05, up 10.86%, on 803,427 volume with 28 trades. The average volume for the last 60 days is 186,654 and the stock's 52-week low/high is $0.0045/$0.059.
Falcon Crest Energy (FCEN)
The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.017, even with yesterday's close. The stock’s average daily volume over the past 60 days is 26,053, and its 52-week low/high is $0.0005/$0.095.
Falcon Crest Energy, Inc. today reaffirmed its optimistic outlook regarding the Company's current position and potential in the Powder River Basin. The Powder River Basin is located in Wyoming, a state many experts forecast as being on the cusp of a second oil boom. The area's untapped oil prospects are rapidly attracting the interest of major energy companies and industry analysts that recognize the tremendous potential of the basin's conventional and tight formations.
Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.
The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.
Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.
Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer
Falcon Crest Energy Company Blog
Falcon Crest Energy News:
Falcon Crest Energy Optimistic About Prospecting in Powder River Basin
Falcon Crest Names Michael Cvetanovic to Advisory Council
Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0019, up 26.67%, on 1,350,500 volume with 16 trades. The stock’s average daily volume over the past 60 days is 3,136,169, and its 52-week low/high is $0.0011/$1.00.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
One World Holdings' Prettie Girls! Dolls Make National TV Debut on Popular Fox Daytime Talk Show, "The Real"
The One World Doll Project Announces First Order From Walmart
The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital
WRIT Media Group, Inc. (WRIT)
The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.0099, up 47.76%, on 66,087 volume with 11 trades. The stock’s average daily volume over the past 60 days is 57,285, and its 52-week low/high is $0.0065/$0.50.
WRIT Media Group, Inc. (WRIT) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.
The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.
Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.
Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.
Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer
WRIT Media Group, Inc. Company Blog
WRIT Media Group, Inc. News:
WRIT Media Group Announces Product Updates and NASCAR Event Recap
Retro Infinity Sponsors NASCAR Driver Carlos Contreras' Record-Breaking 99th Career Race
WRIT Media Group (WRIT) CEO Featured in Exclusive QualityStocks Interview
WordLogic Corp. (WLGC)
The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.0755, up 3.42%, on 91,700 volume with 4 trades. The stock’s average daily volume over the past 60 days is 48,574, and its 52-week low/high is $0.05/$0.235.
WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.
The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.
For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.
Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer
WordLogic Corp. Company Blog
WordLogic Corp. News:
WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
WordLogic (OTCQB:WLGC) Announces that Apple Approves the Launch of an iOS8 Version of the iKnowU Keyboard
WordLogic the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.05, up 1.01%, on 1,033 volume with 3 trades. The stock’s average daily volume over the past 60 days is 4,622, and its 52-week low/high is $0.0031/$0.9412.
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
PURE Announces Retooled Booking Software: 2015 Launch, Slated to Be Industry Regional Leader
Pure Stock Now Available For Retail Trading
Pures 3rd Quarter Filing Shows Promise of Increased Positive Value: Revenue and Hard Assets Prove True
Cleartronic, Inc. (CLRI)
The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.08, even for the day. The stock’s average daily volume over the past 60 days is 2,899, and its 52-week low/high is $0.04/$0.5499.
Cleartronic, Inc.(CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.
VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.
A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.
Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer
Cleartronic, Inc. Company Blog
Cleartronic, Inc. News:
Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
Cleartronic Announces License Agreement With Collabria LLC
Cleartronic, Inc. (CLRI) Developing 'Capitalization Benefit Plan'
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.003, even for the day. The stock’s average daily volume over the past 60 days is 38,093, and its 52-week low/high is $0.003/$0.018.
Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.
Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.
Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Signs License Agreement With NYG Holdings
Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited
Consorteum Holdings Launches New Mobile Results App for Popular Keno Game
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) to Exhibit at China's Largest Food Show
- Cannabics Pharmaceuticals, Inc. (CNBX) engages with Mountain High Products in Colorado
- Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Ecrypt Technologies, Inc. (ECRY) Update Regarding Promotional Activity on Its Stock
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Reaches Technology Development Milestones, Receives Approval From Apple and Google
- Intercept Energy Services, Inc. (IESCF) Reports Third Quarter 2014 Results and Engages Investor Relations Firm
- Mobile Lads Corp. (MOBO) to Launch CouBox, a Next-Generation Mobile Coupon Application
- Nhale, Inc. (NHLE) Expands Acquisition Effort Toward $10 Billion Medical Marijuana Market
- One World Holdings, Inc. (OWOO) Prettie Girls! Dolls Make National TV Debut on Popular Fox Daytime Talk Show, "The Real"
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Pure Hospitality Solutions, Inc. (PNOW) Announces Retooled Booking Software: 2015 Launch, Slated to Be Industry Regional Leader
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Technology Applications International, Inc. (NUUU) Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY® Awards Show at the MGM Grand in Las Vegas
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- WRIT Media Group, Inc. (WRIT) Announces Product Updates and NASCAR Event Recap
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial